BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23354394)

  • 1. A 60day double-blind, placebo-controlled safety study involving Citrus aurantium (bitter orange) extract.
    Kaats GR; Miller H; Preuss HG; Stohs SJ
    Food Chem Toxicol; 2013 May; 55():358-62. PubMed ID: 23354394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine.
    Stohs SJ; Preuss HG; Shara M
    Phytother Res; 2011 Oct; 25(10):1421-8. PubMed ID: 21480414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular Safety of Oral p-Synephrine (Bitter Orange) in Healthy Subjects: A Randomized Placebo-Controlled Cross-over Clinical Trial.
    Shara M; Stohs SJ; Mukattash TL
    Phytother Res; 2016 May; 30(5):842-7. PubMed ID: 26948284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine.
    Stohs SJ; Preuss HG; Shara M
    Int J Med Sci; 2012; 9(7):527-38. PubMed ID: 22991491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety evaluation of p-synephrine following 15 days of oral administration to healthy subjects: A clinical study.
    Shara M; Stohs SJ; Smadi MM
    Phytother Res; 2018 Jan; 32(1):125-131. PubMed ID: 29130542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, Efficacy, and Mechanistic Studies Regarding Citrus aurantium (Bitter Orange) Extract and p-Synephrine.
    Stohs SJ
    Phytother Res; 2017 Oct; 31(10):1463-1474. PubMed ID: 28752649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure and heart rate effects following a single dose of bitter orange.
    Bui LT; Nguyen DT; Ambrose PJ
    Ann Pharmacother; 2006 Jan; 40(1):53-7. PubMed ID: 16317106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of QTc-interval-prolonging or hemodynamic effects of a single dose of bitter-orange extract in healthy subjects.
    Min B; Cios D; Kluger J; White CM
    Pharmacotherapy; 2005 Dec; 25(12):1719-24. PubMed ID: 16305290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological effects following administration of Citrus aurantium for 28 days in rats.
    Hansen DK; George NI; White GE; Pellicore LS; Abdel-Rahman A; Fabricant D;
    Toxicol Appl Pharmacol; 2012 Jun; 261(3):236-47. PubMed ID: 22521485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acute administration of an herbal preparation on blood pressure and heart rate in humans.
    Seifert JG; Nelson A; Devonish J; Burke ER; Stohs SJ
    Int J Med Sci; 2011 Mar; 8(3):192-7. PubMed ID: 21448304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of p-synephrine alone and in combination with selected bioflavonoids on resting metabolism, blood pressure, heart rate and self-reported mood changes.
    Stohs SJ; Preuss HG; Keith SC; Keith PL; Miller H; Kaats GR
    Int J Med Sci; 2011 Apr; 8(4):295-301. PubMed ID: 21537493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometric determination of the predominant adrenergic protoalkaloids in bitter orange (Citrus aurantium).
    Nelson BC; Putzbach K; Sharpless KE; Sander LC
    J Agric Food Chem; 2007 Nov; 55(24):9769-75. PubMed ID: 17966980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of Published Bitter Orange Extract and
    Stohs SJ; Ray SD
    J Diet Suppl; 2020; 17(3):355-363. PubMed ID: 30835576
    [No Abstract]   [Full Text] [Related]  

  • 14. Concentrations of p-synephrine in fruits and leaves of Citrus species (Rutaceae) and the acute toxicity testing of Citrus aurantium extract and p-synephrine.
    Arbo MD; Larentis ER; Linck VM; Aboy AL; Pimentel AL; Henriques AT; Dallegrave E; Garcia SC; Leal MB; Limberger RP
    Food Chem Toxicol; 2008 Aug; 46(8):2770-5. PubMed ID: 18571300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic effects of ephedra-free weight-loss supplements in humans.
    Haller CA; Benowitz NL; Jacob P
    Am J Med; 2005 Sep; 118(9):998-1003. PubMed ID: 16164886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synephrine in dietary supplements and specialized foodstuffs: biological activity, safety and methods of analysis].
    Perova IB; Eller KI; Musatov AV; Tymolskaya EV
    Vopr Pitan; 2021; 90(6):101-113. PubMed ID: 35032130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rapid liquid chromatography electrospray ionization mass spectrometry(n) method for evaluation of synephrine in Citrus aurantium L. samples.
    Mattoli L; Cangi F; Maidecchi A; Ghiara C; Tubaro M; Traldi P
    J Agric Food Chem; 2005 Dec; 53(26):9860-6. PubMed ID: 16366666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of CEDIA amphetamines assay after a single dose of bitter orange.
    Nguyen DT; Bui LT; Ambrose PJ
    Ther Drug Monit; 2006 Apr; 28(2):252-4. PubMed ID: 16628139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute cardiovascular effects of bitter orange extract (p-synephrine) consumed alone and in combination with caffeine in human subjects: A placebo-controlled, double-blind study.
    Ratamess NA; Bush JA; Stohs SJ; Ellis NL; Vought IT; O'Grady EA; Kuper JD; Hasan SB; Kang J; Faigenbaum AD
    Phytother Res; 2018 Jan; 32(1):94-102. PubMed ID: 29047215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Citrus aurantium (bitter orange) fruit extracts and p-synephrine on metabolic fluxes in the rat liver.
    Peixoto JS; Comar JF; Moreira CT; Soares AA; de Oliveira AL; Bracht A; Peralta RM
    Molecules; 2012 May; 17(5):5854-69. PubMed ID: 22592089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.